Atlas Trials

Feasibility of Gallium-68-tilmanocept PET/CT for Sentinel Lymph Node Detection in Endometrial Cancer

Clinical trial NCT05446324 · UNKNOWN

Trial details

NCT number
NCT05446324
Sponsor
UMC Utrecht
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Endometrial Cancer
Start date
2023-02-15
Primary completion
2024-07-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.